EMEA-001298-PIP01-12
Key facts
| Active substance |
Azithromycin
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/0037/2013
|
| PIP number |
EMEA-001298-PIP01-12
|
| Pharmaceutical form(s) |
Age-appropriate dosage form for parenteral use
|
| Condition(s) / indication(s) |
Prevention of bronchopulmonary dysplasia
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Only For Children Pharmaceuticals
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|